Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Tahaluf, Saudi Arabia’s fastest-growing business event organiser, has launched the latest in its vertical industry shows - CPHI Middle East, the region’s premier pharmaceutical event - marking a ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.05% to £19.14 Wednesday, on what proved to be an all-around rough ...

Hikma Pharmaceuticals KSA, announced the expansion of its strategic partnership with the Saudi Gastroenterology Association ...

Global stock markets experienced an uptick on Tuesday as investors held their breath for the US interest rate decision. The ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million ...

Amphastar Pharmaceuticals has seen significant growth since its IPO, with its stock price increasing over 500%. Learn more ...

The acquisition includes a commercial portfolio and pipeline of differentiated products, a manufacturing facility in ...

U.S sterile injectables market is estimated to be valued at US$ 131.8 billion in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period 2022-2030 ...

European markets ended weak on Tuesday, weighed down by losses in automobile, pharmaceutical and biotech sectors. The mood was ...

(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Xellia's FDF ...

In a significant move to mitigate the ongoing shortage of ADHD medications in the U.S., the Drug Enforcement Administration ...